NO20004242D0 - Substituert 1,2,4-triazolo[3,4-a]pyridazin - Google Patents

Substituert 1,2,4-triazolo[3,4-a]pyridazin

Info

Publication number
NO20004242D0
NO20004242D0 NO20004242A NO20004242A NO20004242D0 NO 20004242 D0 NO20004242 D0 NO 20004242D0 NO 20004242 A NO20004242 A NO 20004242A NO 20004242 A NO20004242 A NO 20004242A NO 20004242 D0 NO20004242 D0 NO 20004242D0
Authority
NO
Norway
Prior art keywords
triazolo
pyridazine
substitutes
Prior art date
Application number
NO20004242A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004242L (no
Inventor
William Robert Carling
Tamara Ladduwahetty
Angus Murray Macleod
Kevin John Merchant
Kevin William Moore
Francine Sternfeld
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803992.8A external-priority patent/GB9803992D0/en
Priority claimed from PCT/GB1998/001307 external-priority patent/WO1998050385A1/en
Priority claimed from GBGB9824896.6A external-priority patent/GB9824896D0/en
Priority claimed from PCT/GB1999/000485 external-priority patent/WO1999043677A1/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO20004242L publication Critical patent/NO20004242L/no
Publication of NO20004242D0 publication Critical patent/NO20004242D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20004242A 1998-02-25 2000-08-24 Substituert 1,2,4-triazolo[3,4-a]pyridazin NO20004242D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9803992.8A GB9803992D0 (en) 1998-02-25 1998-02-25 Therapeutic agents
PCT/GB1998/001307 WO1998050385A1 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GBGB9824896.6A GB9824896D0 (en) 1998-11-12 1998-11-12 Therapeutic compound
PCT/GB1999/000485 WO1999043677A1 (en) 1998-02-25 1999-02-17 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE

Publications (2)

Publication Number Publication Date
NO20004242L NO20004242L (no) 2000-08-24
NO20004242D0 true NO20004242D0 (no) 2000-08-24

Family

ID=26313180

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004242A NO20004242D0 (no) 1998-02-25 2000-08-24 Substituert 1,2,4-triazolo[3,4-a]pyridazin

Country Status (8)

Country Link
US (1) US6448249B1 (cs)
KR (1) KR20010041234A (cs)
BR (1) BR9908155A (cs)
CZ (1) CZ291302B6 (cs)
EE (1) EE200000514A (cs)
IL (1) IL137117A0 (cs)
NO (1) NO20004242D0 (cs)
YU (1) YU46500A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI81350C (fi) 1982-01-18 1990-10-10 Lepetit Spa Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat.
IT1194310B (it) 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9503601D0 (en) 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
CA2260900A1 (en) 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the gabaa.alpha.5 receptor subtype
ATE221887T1 (de) 1997-05-08 2002-08-15 Merck Sharp & Dohme Substituierte 1,2,4-triazolo(3,4,-a)phthalazin- derivate als gaba-alpha 5-liganden

Also Published As

Publication number Publication date
IL137117A0 (en) 2001-06-14
BR9908155A (pt) 2000-10-31
KR20010041234A (ko) 2001-05-15
YU46500A (sh) 2002-11-15
NO20004242L (no) 2000-08-24
CZ291302B6 (cs) 2003-01-15
CZ20003114A3 (cs) 2001-01-17
EE200000514A (et) 2002-02-15
US6448249B1 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
GB2340090B (en) Chairs
EP1123023A4 (en) CHAIR
IL210398A0 (en) Novel triazolo (4, 5 - d) pyrimidine
MXPA00012526A (es) Columna mejorada.
MXPA00007634A (es) Nuevos compuestos de triazol (4,5-d) pirimidina.
AU9294998A (en) Thermally conductive carbon foam
NO20004242D0 (no) Substituert 1,2,4-triazolo[3,4-a]pyridazin
AU138567S (en) Chair
IS5575A (is) Setið 1,2,4-tríasóló[3,4-a]pýridasín
IL143530A0 (en) Pyridazinone derivatives
GB9811840D0 (en) Carbon structure
ZA989317B (en) Substituted 1,2,4-triazolo[3,4-A]pyridazine.
HK1030945A (en) Substituted 1,2,4-triazolo[3,4-a]pyridazine
HUP0100647A3 (en) Substituted 1,2,4-triazolo[3,4-a]pyridazine and its pharmaceutical use
GB2334672B (en) The Allenderry chair
CA83600S (en) Chair
CA84971S (en) Chair
CA84175S (en) Chair
CA84218S (en) Chair
CA84787S (en) Chair
CA84878S (en) Chair
CA84880S (en) Chair
CA83601S (en) Chair
CA83602S (en) Chair
CA83495S (en) Chair

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application